Efficacy of triple combination oral hypoglycaemic therapy using rosiglitazone, metformin and sulphonylurea in lowering HbA1C

Practical Diabetes International

Volumn 20, Issue 2, 2003, Pages 58-60

  Byrne, J ^a   Garg, S ^a   Vaidya, A ^a   Rajbhandari, S M ^a   Wallis, S C ^a  

^a LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Oral hypoglycaemic agents; Rosiglitazone; Triple therapy; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; ROSIGLITAZONE; SULFONYLUREA;

ABDOMINAL PAIN; ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD; PRACTICE GUIDELINE; PRESCRIPTION; RETROSPECTIVE STUDY;

EID: 0037346075     PISSN: 13578170     EISSN: None     Source Type: Journal    
DOI: 10.1002/pdi.446     Document Type: Article

References (7)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352(9131): 837-853.
2. Bergenstal RM. Optimization of insulin therapy in patients with type 2 diabetes. Endocr Pract 2000; 6(1): 93-97.
3. National Institute for Clinical Excellence, August 2000 http://www:nice.org.uk/pdf/RosiglitazoneGuidance.pdf
4. National Institute for Clinical Excellence, March 2001. http://www.nice.org.uk/pdf/PioglitazoneGuidance.pdf
5. National Institute for Clinical Excellence. Management of Type 2 Diabetes. Management of Blood Glucose. London: NICE, September 2002.
6. Buch HN, Baskar V, Barton DM, et al. Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes. Diabetic Med 2002; 19: 572-574.
7. Raskin P, Rendell M, Riddle MC, et al. A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes. Diabetes Care 2001; 24(7): 1226-1232.